Salivary Gland Infection Market Size and Share Analysis - Growth Trends and Forecast Report 2024-2032

Salivary Gland Infection Market Trends & Summary

Global Salivary Gland Infection market will grow beyond US$ 4.72 billion by 2032 up from the current US$ 2.93 billion in 2023 and its anticipated to grow at a healthy CAGR of 5.44% during the period of year 2024 to 2032. This has attributed to growing awareness, better technologies in diagnosing and treating the diseases, and enhancement of the salivary gland diseases.

The report Salivary Gland Infection Market & Forecast covers by Type (Diagnosis, Treatment), Application, Hospital, Clinic, Household, Other) Country and Company Analysis 2024-2032.

Global Salivary Gland Infection Market Outlooks

Sialadenitis are infections involving the salivary gland that causes pain, some form of swelling, and may include pus formation due to bacterial or viral invasion. These infections mostly involve the parotid or submandibular salivary gland and may be caused by factors such as dehydration, poor oral hygiene, or presence of structure such as salivary stones.

Pain relief and treatment of a salivary gland infection depends on the location of the infection and ranges from antibiotics to keep bacteria at bay, taking plenty of water and warm compresses as well as massaging the gland as a way of encouraging saliva production. In severe cases, the stones may need to be removed through surgery or if an abscess has developed, has to be drained.

Around the world, more research is being conducted to define better and less invasive approaches towards treating salivary gland infections in the future. This continuous exploration, therefore, is a harbingers of hope signifying that there would be better results and patient satisfaction.

Growth Drivers in the Salivary Gland Infection Market

Increasing Prevalence of Dehydration and Oral Health Issues

Salivary gland infection risk factors include dehydration and poor dental hygiene, high age, and concomitant diseases. With modern people leading a more and more inactive lifestyle, and more and more people take fast food for breakfast, lunch, and dinner, these risk factors are gaining popularity step by step. Because it decreases the secretion of saliva, bacteria gain the opportunity to grow; lack of proper dental hygiene also causes bacterial formation. This rising problem has helped created a market for remedies such as antibiotics and other treatment procedures for the infections. Moreover, salivary gland infection also gets benefitted from the requirement for public health approach linked to enhance the hydration and oral sanitation stabilization all across globe facilitating the demand for preventive & curative therapies. The World Health Organization’s Global Oral Health Status Report for 2022 estimated a figure of 3.5 billion people suffering from oral diseases, and 3 out of 4 people of these are living in the middle-income countries.

Technological Advancements in Diagnostic and Treatment Methods

New technologies in imaging and non-intrusive surgery like sial endoscopy have transformed the approach to the salivary gland infection. Sialendoscopy makes it possible to remove stones and obstructions without extensive surgery and enhance the results in the patients significantly and decrease the time required for healing. Thirdly, advanced technology in imaging such as the ultra-scan and the MRI make it easier to diagnose the infections before they get out of hands through proper imaging. These innovations are contributing to the growth in the salivary gland infection treatment market since it offers better solutions than the conventional ones and make fir treatments to avail in different healthcare facilities across the world. In June 2022, Goodbody Health Inc. launched four saliva tests that can determine a person's risk of getting cancer or heart disease over ten years via looking at genetics. Such launches are expected to propel the segment's growth over the coming years.

Rising Awareness of Salivary Gland Disorders

The general public knowledge in the disorders of the salivary gland infections make people seek medical attention hence boosting the growth of the healthcare industry. Public awareness, health campaigns and the ability to obtain medical information on various forms of digital platform has ensured that the people especially women are become more aware of symtoms and effects of leaving salivary gland infections untreated. This leads to early diagnosis and intervention and thus minimizes one’s possibility of developing more severe health risks. But also, because healthcare professionals are more familiar and more adept in identifying and addressing salivary gland infections given the increased rate that results to a stronger market for the treatments. In the developed countries this awareness is accompanied by insurance which also makes treatments more easily affordable to a larger population.

Salivary Gland Infections Symptoms

Salivary gland infections often cause several noticeable symptoms. These usually include swelling and pain in the infected gland, which often can be observed along the jaw or by the ears. Sometimes, there is more pain when eating because the saliva has difficulty flowing normally. Other symptoms associated with it include dry mouth, the feeling of having a foul-tasting discharge from the gland, and an inability to fully open the mouth. In more serious cases, a patient may also experience fever, chills, and general tiredness, showing signs of potential worsening of the infection. Another symptom is the redness and warmth of the swollen area. It is best to consult the doctor immediately as complications may develop if the condition persists or gets worse.

Treatment of Salivary Gland Infection

Salivary gland infections are treated with antibiotics if caused by bacteria, along with increased fluid intake to encourage saliva flow. Warm compresses and gentle massage of the affected gland can reduce swelling and discomfort. Pain relievers such as ibuprofen or acetaminophen may be prescribed for pain. Drainage may be required in severe infections or abscess formation. Good oral hygiene, hydration, and stimulation of saliva production through sucking on sour candies or chewing sugar-free gum also help in the recovery process. Surgical removal would be necessary in cases of obstruction, such as a salivary stone.

Diagnosis of Salivary Gland Infection

Physical examination is typically the first stage of diagnosing a salivary gland infection. A doctor checks for swelling, tenderness, and redness in the affected gland. It is taken to determine past diseases, such as pain, fever, or dry mouth. With ultrasounds, CT scans, or MRIs in imaging tests, infection may be confirmed if they find blockages, abscesses, or tumors. In suspected cases of bacterial infection, culture on saliva or pus identifies the bacteria responsible and suggests treatment with appropriate antibiotics. Blood tests will be conducted in case of suspicion of systemic infection or underlying diseases.

Best antibiotic for salivary gland infection

The choice of the best antibiotic for the salivary gland infection will depend on the severity and the cause of the infection. Amongst the antibiotics that are frequently used, the drugs include amoxicillin-clavulanate, clindamycin, and cephalexin that have efficacy against the typical pathogens like Staphylococcus aureus and Streptococcus species. More severe cases can be treated intravenously with antibiotics like nafcillin or cefazolin. Trimethoprim-sulfamethoxazole or doxycycline may be given if MRSA is suspected. The treatment can last from 7 to 14 days based on the response of the patient. Other adjunctive treatments are hydration, application of warm compresses, and gentle massage over the gland to aid in healing.

In November 2022, Alembic Pharmaceuticals Ltd informed that a generic Glycopyrrolate injection was soon going to be approved by the US health regulators. This injection minimizes salivary flow and exudation into the airways before surgery.

United States Salivary Gland Infection Market

The United States Salivary Gland Infection market is set to grow due to factors such as increase in the cases of dehydration and poor oral hygiene, and growing awareness about oral health among people. Demographic factors such as increasing population of the elderly, increased rates of systemic diseases, and effects of prevailing diets put into consideration make the chances of salivary gland infections high. The modern diagnostic tools including MRI and ultrasound help in early diagnosis and accurate results which lead to favourable outcomes. Sialendoscopy that is a minimally invasive technique for stone removal has also improved the patient recovery time and help minimize surgery. Further, the access to antibiotics and therapeutic interventions in the U. S. healthcare system perfectly keeps the infections under control, making the market highly resistant and inclined toward the future growth.

Germany Salivary Gland Infection Market

The market for salivary gland infection in Germany is in a growing phase due to better knowledge of oral hygiene and developments in diagnosis systems. Bacterial and viral infections of the salivary gland call for appropriate treatment measures of which include antibiotic and surgery. There has been a rise and persons suffering from conditions like Sjögren’s syndrome and mumps among others meaning that the demand for solutions is ever growing. The geriatric population globally is increasing, and this is a group that is vulnerable to such infections thus leading to penetration and expansion of the market. They aim at new therapies and better diagnostic tools to achieve better results of treatment for patient. Besides, growth in the demand for specialized care and tailored inventions also creates successful strategic partnerships between healthcare and pharmaceutical industries in Germany to maintain competitiveness within the country’s healthcare sector.

China Salivary Gland Infection Market

There is a rising market for salivary gland infection in China owing to infections such as mumps and bacterial sialadenitis. This growth is due to such aspects as increased awareness of the population of oral diseases, as well as the development of infrastructure in the field of health care. The need for a cure for this ailment, which includes antibiotic treatment, anti-inflammatory drugs or surgery if need be, defines the market. Thirdly, the incidence of salivary gland disorders is higher in aging people, which is again fueling the market’s dynamics. Advanced diagnosis through technology, for example, imaging, and other tests are also improving the detection rate and the treatment. The industry players are interested in investing on innovation to bring new therapies.

Saudi Arabia Salivary Gland Infection Market

The following are the factors that are influencing the growth of the salivary gland infection treatment market in Saudi Arabia. This growth can be attributed to the enhancement of knowledge about oral health as well as the current general, more frequent infections, for instance of mumps, bacterial sialadenitis, and so on. In addition, enhanced healthcare system and increasing population increases the necessity of treatment processes, the medication, including antibiotics, and operations. Sjögren’s syndrome, which is especially noticeable in the growing population of the elderly, is also contributing to bringing more personalized and more specialized drugs for treatment. In addition, early diagnostic techniques in imaging and laboratory enhance the treatment outcomes due to early detection. More healthcare growth can be expected from government resolutions aimed at increasing healthcare availability in the region.

Salivary Gland Infection Company Analysis

 Key players in the Salivary Gland Infection Industry include AbbVie Inc., Allergan plc, AstraZeneca, FUJIFILM Holdings Corporation, General Electric Company, GlaxoSmithKline plc, Merck & Co, Pfizer Inc., and Siemens Healthcare GmbH.

Salivary Gland Infection Company News

Nov 2021, Chugai Pharmaceutical Co., Ltd. approved from the Ministry of Health, Labour and Welfare for the use of Herceptin® Injection 60 and 150 (generic name: trastuzumab) in treating advanced or recurrent HER2-positive salivary gland cancer not amenable to curative resection.

Salivary Gland Infection Market Segments

Types - Market is segmented into 2 Viewpoints

1. Diagnosis
2. Treatment

Application - Market is segmented into 4 Viewpoints

1. Hospital
2. Clinic
3. Household
4. Other

Country – Market is segmented into 25 Countries

North America

United States

1. Canada
2. Europe

France

1. Germany
2. Italy
3. Spain
4. United Kingdom
5. Belgium
6. Netherlands
7. Turkey

Asia Pacific

1. China
2. Japan
3. India
4. Australia
5. South Korea
6. Thailand
7. Malaysia
8. Indonesia
9. New Zealand

Latin America

1. Brazil
2. Mexico
3. Argentina

Middle East & Africa

1. South Africa
2. Saudi Arabia
3. United Arab Emirates

Overviews

• Key Person
• Recent Developments & Strategies
• Product Portfolio & Product Launch in Last 1 Year
• Revenue

Key Players Analysis

1. AbbVie Inc.
2. Allergan plc.
3. AstraZeneca
4. FUJIFILM Holdings Corporation
5. General Electric Company
6. GlaxoSmithKline plc.
7. Merck & Co
8. Pfizer Inc.
9. Siemens Healthcare GmbH

Report Details:

Customization Services available

• Analysis of Market Size and Its Segments
• More Company Profiles (Upto 10 without any additional cost):
• Additional Countries (Other than mentioned Countries):
• Region/Country Specific Reports:
• Market Entry Strategy:
• Region-Specific Market Dynamics:
• Regional Market Share Analysis:
• Trade Analysis:
• Production Insights:
• Others Customized Requests:

For more information contact our analysts.

Need More Assistance?

• Talk to our analysts to get more precious information on the current market trends.
• Include more countries and segments and customize the report based on the final requirement.
• Get a competitive advantage in your industry by knowing the report findings and making a positive impact on your revenues and operations.
• Our analysts are always ready to provide more help and pertinent information if you need any additional assistance.